[{"Assets_0_Q1_USD":212896000.0,"CommonStockSharesOutstanding_0_Q1_shares":11897146.0,"EarningsPerShareBasic_1_Q1_USD":-0.15,"EarningsPerShareDiluted_1_Q1_USD":-0.15,"NetIncomeLoss_1_Q1_USD":-1619000.0,"StockholdersEquity_0_Q1_USD":160166000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":10896575.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":10896575.0,"Ticker":"ALBO","CIK":"1322505","name":"ALBIREO PHARMA, INC.","OfficialName":"Albireo Pharma Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688702712.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180510"}]